Menu Search
Equities

Kromek Group PLC

KMK:LSE

Kromek Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)6.40
  • Today's Change-0.150 / -2.29%
  • Shares traded2.08m
  • 1 Year change+28.00%
  • Beta1.3700
Data delayed at least 20 minutes, as of Nov 12 2024 15:28 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Kromek Group PLC grew revenues 12.10% from 17.31m to 19.40m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -6.10m to -3.29m.
Gross margin55.20%
Net profit margin-16.97%
Operating margin-8.35%
Return on assets-4.91%
Return on equity-7.25%
Return on investment-6.46%
More ▼

Cash flow in GBPView more

In 2024, cash reserves at Kromek Group PLC fell by 631.00k. Cash Flow from Financing totalled 7.18m or 36.99% of revenues. In addition the company used 2.80m for operations while cash used for investing totalled 5.00m.
Cash flow per share0.0022
Price/Cash flow per share34.56
Book value per share0.077
Tangible book value per share0.024
More ▼

Balance sheet in GBPView more

Kromek Group PLC has a Debt to Total Capital ratio of 19.93%, a higher figure than the previous year's 11.21%.
Current ratio1.56
Quick ratio0.8917
Total debt/total equity0.249
Total debt/total capital0.1993
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.